Peginterferon Alfa-2a, Ribavirin, Amantadine/Placebo in Hepatitis C Virus (HCV)-Genotype-1-Infection (PRAMA)

NCT00127777 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

700

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis C, Chronic

Interventions

DRUG: Amantadine sulphate (in addition to standard treatment)

Sponsor

University Hospital, Saarland

Collaborators

[object Object]